IBB trailing returns
iShares Biotechnology ETF's 10-year annualized return is +7.5% per year (+105.8% cumulative). How iShares Biotechnology ETF (IBB) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through July 24, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-07-24. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | -0.4% | |
| 1 week | — | -0.9% | |
| 1 month | — | +3.6% | |
| YTD | — | +11.6% | |
| 1 year | +39.3% | +39.3% | |
| 5 years | +2.7% | +14.3% | |
| 10 years | +7.5% | +105.8% | |
| 20 years | +11.2% | +731.3% | |
| Since inception (2001) | +7.0% | +462.5% |
Growth of IBB#
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-07-24). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from IBB's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ
- What is iShares Biotechnology ETF's 10-year return?
- Over the last 10 years, iShares Biotechnology ETF (IBB) returned about +7.5% a year annualized (+105.8% cumulative total return).
- What is iShares Biotechnology ETF's 20-year annualized return?
- Over the last 20 years, iShares Biotechnology ETF (IBB) compounded at about +11.2% a year (+731.3% cumulative).
- What is iShares Biotechnology ETF's return since inception?
- Since 2001, iShares Biotechnology ETF (IBB) has compounded at about +7.0% a year — +462.5% in total.